RSCM
Rock Springs Capital Management’s Puma Biotechnology PBYI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-587,400
| Closed | -$6.32M | – | 137 |
|
2019
Q3 | $6.32M | Buy |
587,400
+53,000
| +10% | +$571K | 0.25% | 93 |
|
2019
Q2 | $6.79M | Buy |
534,400
+76,400
| +17% | +$971K | 0.25% | 90 |
|
2019
Q1 | $17.8M | Buy |
458,000
+1,538
| +0.3% | +$59.7K | 0.69% | 50 |
|
2018
Q4 | $9.29M | Sell |
456,462
-31,138
| -6% | -$634K | 0.44% | 74 |
|
2018
Q3 | $22.4M | Buy |
487,600
+11,800
| +2% | +$541K | 0.81% | 42 |
|
2018
Q2 | $28.1M | Buy |
475,800
+62,900
| +15% | +$3.72M | 1.08% | 26 |
|
2018
Q1 | $28.1M | Buy |
412,900
+39,400
| +11% | +$2.68M | 1.2% | 25 |
|
2017
Q4 | $36.9M | Buy |
373,500
+43,500
| +13% | +$4.3M | 1.68% | 15 |
|
2017
Q3 | $39.5M | Buy |
330,000
+144,000
| +77% | +$17.2M | 1.82% | 12 |
|
2017
Q2 | $16.3M | Buy |
186,000
+91,500
| +97% | +$8M | 0.82% | 45 |
|
2017
Q1 | $3.52M | Hold |
94,500
| – | – | 0.2% | 104 |
|
2016
Q4 | $2.9M | Buy |
94,500
+25,000
| +36% | +$767K | 0.19% | 99 |
|
2016
Q3 | $4.66M | Buy |
69,500
+36,500
| +111% | +$2.45M | 0.29% | 90 |
|
2016
Q2 | $983K | Buy |
33,000
+1,500
| +5% | +$44.7K | 0.07% | 131 |
|
2016
Q1 | $925K | Buy |
31,500
+20,500
| +186% | +$602K | 0.08% | 123 |
|
2015
Q4 | $862K | Sell |
11,000
-4,900
| -31% | -$384K | 0.07% | 117 |
|
2015
Q3 | $1.2M | Buy |
15,900
+4,900
| +45% | +$369K | 0.1% | 117 |
|
2015
Q2 | $1.28M | Sell |
11,000
-13,250
| -55% | -$1.55M | 0.09% | 114 |
|
2015
Q1 | $5.73M | Buy |
24,250
+1,000
| +4% | +$236K | 0.54% | 67 |
|
2014
Q4 | $4.4M | Buy |
23,250
+2,750
| +13% | +$521K | 0.51% | 60 |
|
2014
Q3 | $4.89M | Buy |
+20,500
| New | +$4.89M | 0.76% | 42 |
|
2014
Q2 | – | Sell |
-3,728
| Closed | -$388K | – | 83 |
|
2014
Q1 | $388K | Sell |
3,728
-27,772
| -88% | -$2.89M | 0.09% | 75 |
|
2013
Q4 | $3.26M | Buy |
+31,500
| New | +$3.26M | 1.17% | 25 |
|